Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cidara Therapeutics Reaches Target Enrollment Of Phase 3 ANCHOR Trial Evaluating CD388

Author: Benzinga Newsdesk | November 24, 2025 08:08am

Target enrollment of 6,000 participants completed in the Northern Hemisphere

Planned interim analysis in Q1 2026 will determine potential need for additional enrollment during Southern Hemisphere flu season

Posted In: CDTX